After exhaustive analysis of the cholesterol pathway, they identified cholesteryl esters (CE), the storage product of excess cholesterol, as upstream regulators of Tau early during AD development, with CE also regulating Aβ secretion via independent pathways. Here, MAPT is linked to Alzheimer disease.